Revance Therapeutics Inc (RVNC) volume exceeds 1.58 million: A new investment opportunity for investors
On Friday, Revance Therapeutics Inc (NASDAQ: RVNC) was -6.98% down from the session before settling in for the closing price of $4.44. A 52-week range